Adjusted Earnings Before Interest Taxes Depreciation and Amortization and IFRS voodoo on Gain on Bios and any "Other Income/Expenses". Interesting to reflect back on the Gross Margin and chart and note the ordinal ranking. Top 4 Gross Margin are also Top 4 for +EBITDA. .Note the colours are not the same, so you'll need to look at the index.
As we finally start getting "clean" (eg. with no need to back-out 9 month YTD from Annual Reports) Quarterly earnings reports from recently public US MSOs, we can start doing Peer Comparisons and Trend Analysis. And boy howdy, do I have a lot of graphs coming your way. This one is what the implied Breakeven Sales required to evidence a positive Net Operating Profit. As you can see, both Trulieve and CWEB have already achieved +NOP, so they are under 100%. If you remember the North American Gross Margin Peer I hung up early this week... you can see why I am harping on…
Tilray reports in US GAAP, so no Bio Assets.
With iAnthus being talked up... I thought I would put this up.
Canopy does not disclose Projected Yield in Notes to Bio Assets.